TAM
VRTX icon

Tucker Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Tucker Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.08K Buy
+9
New +$3.88K ﹤0.01% 719
2025
Q1 		– Sell
-6
Closed -$2.42K – 926
2024
Q4 		$2.42K Hold
6
– – ﹤0.01% 1169
2024
Q3 		$2.79K Hold
6
– – ﹤0.01% 1093
2024
Q2 		$2.81K Hold
6
– – ﹤0.01% 1230
2024
Q1 		$2.51K Buy
+6
New +$2.54K ﹤0.01% 1271

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Tucker Asset Management's VRTX Position: Q4 2025 in Review

Tucker Asset Management opened a new position in Vertex Pharmaceuticals (VRTX) in Q4 2025: 9 shares worth $4.08K. The stake represents ﹤0.01% of the portfolio and ranks #719 among its holdings. This is a return to the name: Tucker Asset Management previously reported a position in VRTX as recently as Q4 2024.

Tucker Asset Management first reported a position in VRTX in Q1 2024 and has held it in 5 quarters since. 1,668 funds tracked by Wall St. Rank hold VRTX as of Q4 2025.

  • Tucker Asset Management held 9 shares of Vertex Pharmaceuticals worth $4.08K as of Q4 2025.
  • Vertex Pharmaceuticals was a new Tucker Asset Management position in Q4 2025.
  • Vertex Pharmaceuticals made up ﹤0.01% of Tucker Asset Management's portfolio in Q4 2025, its #719 holding.
  • Tucker Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 5 quarters since.
  • 1,668 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2025.

Based on Tucker Asset Management's 13F filing for Q4 2025, filed 5 Feb 2026.